Emerson Q2 Earnings Conference Call

May 5, 2021

Emerson's DeltaV control platform, installed at over 3000 life science facilities worldwide, helps customers ensure quality, compliance, and optimize research and production of critical medicines and vaccines.

.

Safe Harbor Statement

Statements in this presentation and our commentary and responses to questions that are not strictly historical may be "forward-looking" statements, which involve risks and uncertainties, and Emerson undertakes no obligation to update any such statements to reflect later developments. These risks and uncertainties include the scope, duration and ultimate impact of the COVID-19 pandemic, as well as economic and currency conditions, market demand, including related to the pandemic and oil and gas price declines and volatility, pricing, protection of intellectual property, cybersecurity, tariffs, competitive and technological factors, among others, as set forth in the Company's most recent Annual Report on Form 10-K and subsequent reports filed with the SEC.

Non-GAAP Measures

In this call we will discuss some non-GAAP measures (denoted with *) in talking about our company's performance, and

the reconciliation of those measures to the most comparable GAAP measures is contained within this presentation or available at our website www.Emerson.com

under Investors.

2

Emerson's latest ESG report will be published in June, highlighting our

goals, momentum, and references to multiple global standards

3

3

The Emerson Global User Exchange Virtual Series has expanded our engagement with customers on key digital and sustainability topics

Attendees

Expanding Customer Engagement

12,000+

Registered Attendees

50%

100+

Customers new to

Countries

Exchange in 2021

Roadmaps & Presentations

Addressing Industry Dynamics

Digital Transformation & Sustainability

Technology Roadmaps

Over 40 Emerson technology roadmaps

Product Demonstrations & Expo Booths Over 20,000 visits

Dedicated Expert Engagement Over 250 Emerson expert consultative meetings

Keynotes & Case Studies

Users Sharing Best Practice With Users

130+

User Case Studies

Moderna Vaccine

BP Sustainability

Keynote Address

Keynote Address

4

Q2 Performance and Updated Guidance

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Emerson Electric Co. published this content on 05 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 May 2021 11:10:05 UTC.